Company Filing History:
Years Active: 2018
Title: Akila Parvathy Dharshinis: Innovator in CCR9 Modulation
Introduction
Akila Parvathy Dharshinis is a notable inventor based in Thirunelveli, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the CCR9 receptor. His work is crucial for addressing various inflammatory and immune disorders.
Latest Patents
Dharshinis holds a patent for "Compounds useful as CCR9 modulators." This invention relates to compounds that can modulate the function of the CCR9 receptor by acting as partial agonists, antagonists, or inverse agonists. These compounds are particularly useful in treating, preventing, or ameliorating diseases associated with CCR9 activation, including inflammatory bowel diseases (IBD).
Career Highlights
Currently, Akila Parvathy Dharshinis is associated with Norgine Bv, where he continues to innovate in the field of pharmaceutical development. His expertise in CCR9 modulation positions him as a key player in the research and development of new therapeutic options.
Collaborations
Dharshinis has collaborated with notable colleagues such as Rajagopal Bakthavatchalam and Manas Kumar Basu. These collaborations enhance the research efforts in developing effective treatments for immune-related conditions.
Conclusion
Akila Parvathy Dharshinis is a pioneering inventor whose work on CCR9 modulators holds promise for advancing treatments for inflammatory diseases. His contributions to medicinal chemistry are invaluable and continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.